| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1994;57:1211-1216
© 1994 The Society of Thoracic Surgeons
Overholt Division of Cardiothoracic Surgery, the New England Deaconess Hospital and Harvard Medical School, Boston, Massachusetts, USA
Accepted for publication August 23, 1993.
* Address reprint requests to Dr Berger, 135 Francis St, Boston, MA 02215.
Heparin resistance, defined as failure of 500 IU per kilogram of body weight of heparin to prolong the activated clotting time (ACT) to 480 seconds or longer, was noted during 949 of 4,280 (22%) consecutive open heart surgical procedures performed on adults between 1986 and 1991. The total population was divided into the following four groups; group 1, preoperative intraaortic balloon support without concomitant heparin therapy (n = 138 patients); group 2, preoperative intravenous heparin therapy (n = 741 patients); group 3, intraaortic balloon support with concomitant intravenous heparin therapy (n = 137 patients); and group 4, controls, not receiving preoperatively the therapy given groups 1, 2, or 3 (n = 3,264 patients). The ACT response to an initial dose of 500 lU/kg of heparin and the incidence of heparin resistance were 596 ± 203 seconds and 30% in group 1; 506 ± 149 seconds and 50% in group 2; 520 ± 159 seconds and 53% in group 3; and 705 ± 234 seconds and 14% in group 4, respectively. These results indicate that preoperative intravenous therapy and intraaortic balloon support are associated with a decreased ACT response to intraoperative heparin. Baseline ACT levels and preoperative platelet counts were not predictive of heparin resistance. A reduced ACT response to the initial dose of heparin was associated with increased requirements for supplementary anticoagulant therapy during the ensuing period on cardiopulmonary bypass, indicating that the decreased sensitivity to heparin extends beyond the initial episode of heparinization. These data reveal that preoperative intraaortic balloon support and intravenous heparin therapy are associated with a heightened resistance to heparin, necessitating modifications in the standard heparin dose schedule and mandating close surveillance of ACT for the duration of cardiopulmonary bypass.
This article has been cited by other articles:
|
|
 |
|
  V. Muedra, S. Bonanad, M. Gomez, V. Villalonga, F. Sanchez, and J. E. Llopis Relationships between antithrombin activity, anticoagulant efficacy of heparin therapy and perioperative variables in patients undergoing cardiac surgery requiring cardiopulmonary bypass Perfusion, November 1, 2011; 26(6): 487 - 495. [Abstract] [PDF]
|
|
|
|
 |
|
 J. H. Levy and R. M. Sniecinski Activated Clotting Times, Heparin Responses, and Antithrombin: Have We Been Wrong All These Years? Anesth. Analg., October 1, 2010; 111(4): 833 - 835. [Full Text] [PDF]
|
|
|
|
|
|
S. Garvin, D. Fitzgerald, J. D. Muehlschlegel, T. E. Perry, A. A. Fox, S. K. Shernan, C. D. Collard, S. Aranki, and S. C. Body Heparin Dose Response Is Independent of Preoperative Antithrombin Activity in Patients Undergoing Coronary Artery Bypass Graft Surgery Using Low Heparin Concentrations Anesth. Analg., October 1, 2010; 111(4): 856 - 861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. Lund, G. Wassback, O. Thomas, T. Carlsson, and U. Schott Comparison of two infusion rates of antithrombin concentrate in cardiopulmonary bypass surgery Perfusion, September 1, 2010; 25(5): 305 - 312. [Abstract] [PDF]
|
|
|
|
|
|
K. A. Tanaka, N. S. Key, and J. H. Levy Blood Coagulation: Hemostasis and Thrombin Regulation Anesth. Analg., May 1, 2009; 108(5): 1433 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. D. Spiess Treating Heparin Resistance With Antithrombin or Fresh Frozen Plasma Ann. Thorac. Surg., June 1, 2008; 85(6): 2153 - 2160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Cooper Jr, J. Abrams, O.H. Frazier, R. Radovancevic, B. Radovancevic, A. W. Bracey, M. J. Kindo, and I. D. Gregoric Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: Possible association with antifibrinolytic therapy J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 963 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Chan, N. C. Hwang, and C. H. Lim A statistical analysis of factors predisposing patients to heparin resistance Perfusion, March 1, 2006; 21(2): 99 - 103. [Abstract] [PDF]
|
|
|
|
|
|
M. Ranucci, G. Isgro, A. Cazzaniga, A. Ditta, A. Boncilli, M. Cotza, G. Carboni, and S. Brozzi Different patterns of heparin resistance: therapeutic implications Perfusion, May 1, 2002; 17(3): 199 - 204. [Abstract] [PDF]
|
|
|
|
|
|
J. H. Lemmer Jr and G. J. Despotis Antithrombin III concentrate to treat heparin resistance in patients undergoing cardiac surgery J. Thorac. Cardiovasc. Surg., February 1, 2002; 123(2): 213 - 217. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Nicholson, D. M. Keeling, M. E. Sinclair, and R. D. Evans Heparin pretreatment does not alter heparin requirements during cardiopulmonary bypass Br. J. Anaesth., December 1, 2001; 87(6): 844 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Vuylsteke, R. J. Mills, A. E. Crosbie, T. I. Burns, and R. D. Latimer Increased pre-operative platelet counts are a possible predictor for reduced sensitivity to heparin Br. J. Anaesth., December 1, 2000; 85(6): 896 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Williams, A. B. D'Ambra, J. R. Beck, T. B. Spanier, D. L.S. Morales, D. N. Helman, and M. C. Oz A randomized trial of antithrombin concentrate for treatment of heparin resistance Ann. Thorac. Surg., September 1, 2000; 70(3): 873 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. H. Levy, F. Montes, F. Szlam, and C. D. Hillyer The In Vitro Effects of Antithrombin III on the Activated Coagulation Time in Patients on Heparin Therapy Anesth. Analg., May 1, 2000; 90(5): 1076 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ranucci, G. Isgro, A. Cazzaniga, G. Soro, L. Menicanti, and A. Frigiola Predictors for heparin resistance in patients undergoing coronary artery bypass grafting Perfusion, December 1, 1999; 14(6): 437 - 442. [Abstract] [PDF]
|
|
|
|
 |
|
 A. S. Weisinger and J. H. Levy Current Hematologic Issues in Cardiac Surgery and Cardiopulmonary Bypass Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1998; 2(4): 259 - 271. [Abstract] [PDF]
|
|
|
|
|
|
P. Robbins, M. Forrest, and D. Royston Hypercoagulable States Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 295 - 318. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
